1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor mutational burden predicts progression-free survival and local-regional control in locally advanced non-small cell lung cancer patients treated with chemoradiation and durvalumab
    Meeting Abstract

    Shaverdian, N.; Shepherd, A. F.; Offin, M.; Gelblum, D.; Wu, A. J.; Simone, C. B. 2nd; Schoenfeld, A. J.; Jones, D.; Rimner, A.; Chaft, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • FOLFOX-based chemoradiation as non-operative management for esophageal adenocarcinoma
    Meeting Abstract

    Rouf, R.; Ku, G.; Cowzer, D.; Harrington, C.; Maron, S.; Janjigian, Y.; Ilson, D. H.; Molena, D.; Sihag, S.; Hajj, C.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Characteristics of patients who survived more than 5 years after diagnosis of melanoma brain metastases
    Meeting Abstract

    Gui, C.; Wolchok, J. D.; Postow, M. A.; Betof Warner, A.; Loo, K.; Brennan, C. W.; Moss, N. S.; Tabar, V. S.; Beal, K.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Systematic literature review and meta-analysis on use of thrombopoietic agents for chemotherapy-induced thrombocytopenia
    Review

    Soff, G. A.; Ray-Coquard, I.; Rivera, L. J. M.; Fryzek, J.; Mullins, M.; Bylsma, L. C.; Park, J. K.
    PLoS ONE (2022)

    Fulltext@MSK | Save
  • Role of CD19 chimeric antigen receptor T cells in second-line large B cell lymphoma: Lessons from phase 3 trials. An expert panel opinion from the American Society for Transplantation and Cellular Therapy
    Review

    Perales, M. A.; Anderson, L. D. Jr; Jain, T.; Kenderian, S. S.; Oluwole, O. O.; Shah, G. L.; Svoboda, J.; Hamadani, M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Real-world evidence of axicabtagene ciloleucel for the treatment of Large B cell lymphoma in the United States
    Journal Article

    Jacobson, C. A.; Locke, F. L.; Ma, L.; Asubonteng, J.; Hu, Z. H.; Siddiqi, T.; Ahmed, S.; Ghobadi, A.; Miklos, D. B.; Lin, Y.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • ASTCT Committee on Practice Guidelines survey on Evaluation & management of diffuse large B-cell lymphoma after failure of chimeric antigen receptor T cell therapy (CAR-T) therapy
    Journal Article

    Ahmed, N.; Kumar, A.; Kharfan-Dabaja, M. A.; DeFilipp, Z.; Herrera, A.; Hashmi, S.; Dholaria, B.; Perales, M. A.; Carpenter, P. A.; Hamadani, M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial
    Journal Article

    Jahn, N.; Jahn, E.; Saadati, M.; Bullinger, L.; Larson, R. A.; Ottone, T.; Amadori, S.; Prior, T. W.; Brandwein, J. M.; Appelbaum, F. R.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • Management of chronic myeloid leukemia in children and young adults
    Review

    Ford, M.; Mauro, M.; Aftandilian, C.; Sakamoto, K. M.; Hijiya, N.
    Current Hematologic Malignancy Reports (2022)

    Fulltext@MSK | Save
  • Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma
    Research Letter

    Kurtansky, N. R.; Manci, R. N.; Bello, D. M.; Adamson, A. S.; Shoushtari, A. N.; Wehner, M. R.; Ariyan, C. E.; Marghoob, A. A.; Marchetti, M. A.; Rotemberg, V.
    British Journal of Dermatology (2022)

    Fulltext@MSK | Save